Pfizer Inc. announces FDA approval of DUAVEETM for the treatment of moderate-to-severe vasomotor symptoms associated with menopause and the prevention of postmenopausal osteoporosis
“The approval of DUAVEE, an important, novel and effective treatment,…
3 October 2013 | By Pfizer Inc.
“The approval of DUAVEE, an important, novel and effective treatment, presents a new opportunity for women..."